|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Decubitus Ulcer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Pressure Ulcer | |||||
| Ulcer | |||||
| 3 | More general conditions related to this trial | ||||
| Pathologic Processes | |||||
| Skin Diseases | |||||
| Skin Ulcer | |||||
| 4 | Interventions listed in this trial | ||||
| Pain relief for pressure ulcers | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Morphine | |||||
| 6 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Opioid | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Depressants | |||||
| Narcotics | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | |||||